Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-31 Purchase | 2022-01-31 6:47 pm | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner | 800,000 | $27 | $21,600,000 | 2,735,853 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-09 Disposition | 2024-10-10 5:15 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 2,695 | $1000 | 9,974,037 (Indirect) | View |
| 2024-10-09 Conversion | 2024-10-10 5:15 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 5,500,000 | $0 | 9,974,037 (Indirect) | View |
| 2024-05-09 Option Award | 2024-05-10 4:05 pm | N/A 2034-05-08 | GERON CORP | GERN | Aggarwal Gaurav Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 7:02 pm | N/A N/A | GERON CORP | GERN | Aggarwal Gaurav Director | 1,970 | $0 | 1,970 (Direct) | View |
| 2023-11-26 Option Award | 2023-11-28 4:10 pm | N/A 2033-11-25 | GERON CORP | GERN | Aggarwal Gaurav Director | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 4:30 pm | 2024-09-05 2033-09-05 | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-07-11 Conversion | 2023-07-13 8:42 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 8,077 | $1000 | 59,961,729 (Indirect) | View |
| 2023-07-11 Conversion | 2023-07-13 8:42 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 59,961,729 | $0 | 59,961,729 (Indirect) | View |
| 2023-03-08 Option Award | 2023-03-09 9:39 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 8,077 | $1000 | 8,077 (Indirect) | View |
| 2022-07-01 Disposition | 2022-07-01 4:45 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director | 2,735,853 | $55 | 0 (Indirect) | View |
| 2022-07-01 Disposition | 2022-07-01 4:45 pm | N/A 2029-11-29 | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director | 1,469,758 | $0 | 0 (Direct) | View |
| 2022-01-26 Exercise | 2022-01-28 7:53 pm | 2020-01-22 N/A | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner | 1,935,661 | $13.2 | 1,935,853 (Indirect) | View |
| 2021-06-08 Option Award | 2021-06-09 10:29 am | N/A 2031-06-08 | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-10 6:58 pm | N/A 2030-06-09 | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner | 6,874 | $0 | 6,874 (Direct) | View |
| 2020-01-29 Conversion | 2020-01-31 4:56 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner | 1,474,789 | $0 | 1,455,576 (Indirect) | View |